Stimulation of Sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats

2009 ◽  
Vol 13 (11) ◽  
pp. 1253-1265 ◽  
Author(s):  
Md. Shenuarin Bhuiyan ◽  
Kohji Fukunaga
2013 ◽  
Vol 113 (suppl_1) ◽  
Author(s):  
Hideaki Tagashira ◽  
Takayuki Matsumoto ◽  
Kumiko Taguchi ◽  
Tsuneo Kobayashi ◽  
Kohji Fukunaga

Objective: We previously reported that sigma-1 receptor ( σ 1 R ) expression in the thoracic aorta decreased after pressure overload (PO) induced by abdominal aortic banding in ovariectomized (OVX) rats. Here, we asked whether stimulation of σ 1 R with the selective agonist SA4503 elicits functional recovery of aortic vasodilation and constriction following vascular injury in OVX rats with PO. Methods: SA4503 (0.3-1.0 mg kg -1 ) and NE-100 (an σ 1 R antagonist, 1.0 mg kg -1 ) were administered orally for 4 weeks (once daily) to OVX-PO rats, starting from the onset of aortic banding. Vascular functions of isolated descending aorta were measured following phenylephrine (PE)- or endothelin-1 (ET-1)-induced vasoconstriction and acetylcholine (ACh)- or clonidine-induced vasodilation. Results: σ 1 R expression in aortic smooth muscle and endothelial cells decreased significantly 4 weeks after PO in OVX rats (vs. Sham or OVX only group). SA4503 administration rescued PO-induced σ 1 R decreases in the descending aorta. SA4503 treatment also rescued PO-induced impairments in ACh- and clonidine-induced vasodilation without affecting PE- and ET-1-induced vasoconstriction. Ameliorated ACh- and clonidine-induced vasodilation was closely associated with increased Akt activity and in turn endothelial nitric oxide synthase (eNOS) phosphorylation. SA4503-mediated improvement of vasodilation was blocked by NE-100 treatment. Conclusions: σ 1 R is downregulated following PO-induced endothelial injury in OVX rats. The selective σ 1 R agonist SA4503 rescues impaired endothelium-dependent vasodilation in the aorta from OVX-PO rats through σ 1 R stimulation, enhancing eNOS-cGMP signaling in vascular endothelial cells. These observations encourage development of novel therapeutics targeting σ 1 R to prevent vascular endothelial injury in postmenopausal woman.


2018 ◽  
Vol 315 (6) ◽  
pp. H1521-H1531 ◽  
Author(s):  
Xin Liu ◽  
Chuan Qu ◽  
Hongjie Yang ◽  
Shaobo Shi ◽  
Cui Zhang ◽  
...  

The present study aimed to assess the effect of sigma-1 receptor (S1R) stimulation on autonomic nerve dysfunction and susceptibility to atrial fibrillation (AF) in a rat depression model. Male rats were randomly divided into one of the following four treatment groups: saline [control (CTL)]; saline + intragastric administration of SA4503, an agonist of S1R (CTS); chronic unpredictable mild stress (CUMS) to produce depression (MDD); and CUMS + intragastric administration of SA4503 (MDS). Depression-like behaviors, such as reduced sucrose preference, decreased body weight gain, and increased immobility time during forced swimming, improved in the MDS group after 4 wk of SA4503 treatment. Compared with rats in the CTL group, rats in the MDD group showed significantly augmented sympathetic activity, reduced parasympathetic activity, decreased heart rate variability, and lowered S1R expression in the atrium and hippocampus (all P < 0.01). However, rats in the MDS group showed mitigated aforementioned alterations and improved electrical remodeling compared with rats in the MDD group (all P < 0.01). Furthermore, rats in the MDS group showed shortened activation latencies, increased effective refractory periods, and lowered frequency of AF incidence duration and fibrosis compared with rats in the MDD group (all P < 0.01). The results indicate that S1R stimulation reduces sympathetic activity and susceptibility to AF by improving depressive behaviors, modulating cardiac autonomic nerve balance, lightening nerve remodeling, and upregulating S1R and ion channel protein expression. NEW & NOTEWORTHY Chronic stimulation of the sigma-1 receptor (S1R) ameliorates depression-induced autonomic nerve dysfunction by modulating the imbalance between overactivated sympathetic activity and decreased vagal activity. Chronic S1R stimulation alleviates atrial electrical remodeling, fibrosis, and susceptibility to atrial fibrillation (AF). The S1R agonist may target the underlying mechanisms related to AF occurrence. The results indicate that the S1R could be a potential clinical target for atrial arrhythmia, especially when it is combined with major depressive disorders.


2014 ◽  
Vol 52 (3) ◽  
pp. 1210-1222 ◽  
Author(s):  
Shigeki Moriguchi ◽  
Hiroyuki Sakagami ◽  
Yasushi Yabuki ◽  
Yuzuru Sasaki ◽  
Hisanao Izumi ◽  
...  

2006 ◽  
Vol 20 (4) ◽  
Author(s):  
Felix J Kim ◽  
Ivanka Kovalyshyn ◽  
Gavril W Pasternak

2010 ◽  
Vol 14 (10) ◽  
pp. 1009-1022 ◽  
Author(s):  
Md. Shenuarin Bhuiyan ◽  
Hideaki Tagashira ◽  
Norifumi Shioda ◽  
Kohji Fukunaga

PLoS ONE ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. e60863 ◽  
Author(s):  
Shigeki Moriguchi ◽  
Yasuharu Shinoda ◽  
Yui Yamamoto ◽  
Yuzuru Sasaki ◽  
Kosuke Miyajima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document